Hepatitis Clinical Trials in Dallas, Texas
11 recruitingDallas, Texas
Showing 1–11 of 11 trials
Recruiting
Phase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc.120 enrolled15 locationsNCT07335601
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
Phase 2
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
Chronic Hepatitis B
Gilead Sciences150 enrolled62 locationsNCT02932150
Recruiting
Phase 3
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Hepatitis
Bausch Health Americas, Inc.350 enrolled48 locationsNCT07428538
Recruiting
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
Target PharmaSolutions, Inc.15,000 enrolled74 locationsNCT02815891
Recruiting
The Hepatitis C Transplant Collaborative
Transplant; Failure, HeartHepatitis C
Baylor Research Institute500 enrolled1 locationNCT04493385
Recruiting
Phase 2
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis
Boston Pharmaceuticals42 enrolled35 locationsNCT06920043
Recruiting
Not Applicable
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NASH - Nonalcoholic Steatohepatitis
Perspectum225 enrolled7 locationsNCT04054310
Recruiting
Phase 4
National Liver Cancer Screening Trial
Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Autoimmune HepatitisPrimary Sclerosing Cholangitis
Children's Hospital Medical Center, Cincinnati800 enrolled8 locationsNCT05750498
Recruiting
Phase 2
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Alcohol Associated Hepatitis
Intercept Pharmaceuticals80 enrolled31 locationsNCT05639543